Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis.
about
Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacyThe Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens.Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4.Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic ScienceProbiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.Clinical use of E. coli Nissle 1917 in inflammatory bowel disease.Distinct Commensals Induce Interleukin-1β via NLRP3 Inflammasome in Inflammatory Monocytes to Promote Intestinal Inflammation in Response to InjuryBerberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity.Host and microbiota factors that control Klebsiella pneumoniae mucosal colonization in mice.Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.Impact of metal ion homeostasis of genetically modified Escherichia coli Nissle 1917 and K12 (W3110) strains on colonization properties in the murine intestinal tract.Rationale for probiotic treatment strategies in inflammatory bowel disease.Traditional Chinese Medicine QPYF as Preventive Treatment for Clostridium difficile Associated Diarrhea in a Mouse Model.Probiotic yogurt Affects Pro- and Anti-inflammatory Factors in Patients with Inflammatory Bowel Disease.Lessons from probiotic-host interaction studies in murine models of experimental colitis.Importance of IL-10 modulation by probiotic microorganisms in gastrointestinal inflammatory diseases.Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases.Impact of a probiotic Enterococcus faecalis in a gnotobiotic mouse model of experimental colitis.Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells.Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.Live and heat-killed probiotic: effects on chronic experimental colitis induced by dextran sulfate sodium (DSS) in rats.The translocation kinetics of antibiotics through porin OmpC: insights from structure-based solvation mapping using WaterMap.Oral administration of taurolidine ameliorates chronic DSS colitis in mice.Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.Effects of probiotic Lactobacillus rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS supplementation on intestinal and systemic markers of inflammation in ApoE*3Leiden mice consuming a high-fat diet.Bifidobacterium longum subsp. infantis BB-02 attenuates acute murine experimental model of inflammatory bowel disease.Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin.Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells.Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel DiseasesCommensal gut bacteria: distribution of Enterococcus species and prevalence of Escherichia coli phylogenetic groups in animals and humans in Portugal
P2860
Q33503647-0B39996B-1737-4FB5-A784-AB634627AC5BQ33639134-74D07525-62B2-4AC8-BEDA-100034939C56Q33651733-F28456D6-EEC5-4549-8A5C-CDF6B87EE483Q33684740-73EA9FD4-DD2C-49B5-A559-D1AB43FBE4ECQ34162963-9D7B1B93-FCAC-4044-AB28-78AB4D96DC96Q34588415-4EFE1B96-7889-4B39-B11C-DD749ADEDCACQ34744012-1614C7CF-A34E-4D7B-838D-F8023F3C2BE0Q35533509-67CBB9B6-EE64-4538-8FF6-06F0F0835DEFQ35590543-D308C797-1ECA-43DD-815C-8952EF8FB0F7Q36392065-FEE0A3F1-BB3B-4B49-BF5B-80869102D01DQ37079287-E7040048-F880-48C3-8D4A-4B08E5413EB9Q37082773-6D5E6C42-6DB2-45B7-A762-111FE33D58B8Q37320020-326459AF-337F-476E-8AFC-9833786691C8Q37345932-36A09D23-DED4-47BD-822B-0FA6B3C9672AQ37483380-025C07B8-913B-4144-9441-8C147C22E2F5Q37576939-6A34A0DF-FDED-440A-A66D-1281389A8D1EQ37907198-8EFE8CD4-8FC7-4EF3-936B-0FC418A080C8Q38339037-29534DC1-04EA-4FE3-8F91-8DFA4956ED78Q39127400-39D641FF-983F-4965-BEC4-DD68EC7429D9Q39604749-EC9A1146-92FB-4E61-9DF7-4C0F1832235EQ40060675-82F30E9A-5EE7-42E5-A92F-97548B426C9CQ40264330-55356FAC-BC98-479E-B993-E064A4CCAB90Q42134713-8A94FB0A-5287-4591-BE21-14E9ED8A17F5Q45855155-148AB371-140D-4761-990C-BBE4BE00044EQ46922561-0179A94E-309D-44C7-AB7A-7CDCCF1BEA36Q50454240-62A3F65C-D1EC-4BA2-9338-2C32F2A94769Q50795525-127EE38F-8CAE-44B5-BE39-A7E054E3B6EDQ51035866-709E5FAF-2DAD-43C2-A15A-44C4F1DA1EF2Q54425261-74EDDFDE-207F-4FCB-90B5-9160026B6002Q54467599-DC7D7877-5B8B-4966-9790-790F13C72539Q58694467-C1503F58-A712-4AEC-B1AB-6D03D506F88EQ58873697-4B2D5A4E-4EFA-478E-A66E-B7F470C291AF
P2860
Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.
@ast
Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.
@en
Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.
@nl
type
label
Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.
@ast
Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.
@en
Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.
@nl
prefLabel
Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.
@ast
Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.
@en
Nonpathogenic Escherichia coli ...... ine acute and chronic colitis.
@nl
P2093
P2860
P1476
Nonpathogenic Escherichia coli ...... rine acute and chronic colitis
@en
P2093
Hiroshi Chinen
Kanji Tsuchimoto
Katsuyoshi Matsuoka
Kyong Su Hong
Nagamu Inoue
Noriaki Watanabe
Susumu Okamoto
Tadakazu Hisamatsu
Takaya Yamada
Tatsuo Suzuki
P2860
P304
P356
10.1097/01.MIB.0000158158.55955.DE
P577
2005-05-01T00:00:00Z